Long-term outcomes of the 2-week schedule of hypofractionated radiotherapy for recurrent hepatocellular carcinoma.
Jongmoo ParkJinhong JungDaegeun KimIn-Hye JungJin-Hong ParkJong Hoon KimSang-Wook LeeSang Min YoonPublished in: BMC cancer (2018)
The 2-week schedule of hypofractionated radiotherapy for recurrent HCC exhibited good local control and acceptable treatment-related toxicity during the long-term follow-up period. Thus, this fractionation schedule can be a potential salvage treatment option for recurrent HCC, particularly for tumors located close to a radiosensitive gastrointestinal organ.